Table 2 Baseline quality of life scores stratified by prior treatment history
From: Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer
Baseline variable | Newly diagnosed | Previously treated | P |
|---|---|---|---|
(N = 28) | (N = 109) | ||
Mean (standard deviation) | Mean (standard deviation) | ||
General quality of life | |||
Global | 58.9 (29.7) | 60.0 (22.7) | 0.83 |
General function | |||
Physical | 76.1 (22.2) | 76.8 (23.0) | 0.89 |
Role | 61.9 (32.9) | 68.1 (31.1) | 0.34 |
Emotional | 68.4 (26.8) | 70.6 (23.0) | 0.66 |
Cognitive | 79.1 (25.9) | 78.1 (22.1) | 0.83 |
Social | 63.6 (33.9) | 67.2 (32.7) | 0.60 |
General symptom | |||
Fatigue | 42.8 (30.7) | 39.3 (27.8) | 0.56 |
Nausea/vomiting | 11.3 (23.5) | 13.6 (22.2) | 0.63 |
Pain | 25.0 (29.2) | 29.3 (28.4) | 0.47 |
Dyspnea | 17.8 (26.4) | 22.3 (28.3) | 0.45 |
Insomnia | 33.3 (31.4) | 39.7 (34.6) | 0.37 |
Appetite loss | 28.5 (41.2) | 18.6 (25.0) | 0.10 |
Constipation | 15.4 (26.4) | 23.8 (29.4) | 0.17 |
Diarrhea | 11.9 (24.3) | 15.9 (24.6) | 0.44 |
Financial | 29.7 (34.3) | 34.5 (32.3) | 0.49 |